Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
J Laryngol Otol ; 134(12): 1103-1107, 2020 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-33431081

RESUMO

OBJECTIVE: Wide-ranging outcomes have been reported for surgical and non-surgical management of T3 laryngeal carcinomas. This study compared the outcomes of T3 tumours treated with laryngectomy or (chemo)radiotherapy in the northeast of England. METHODS: The outcomes of T3 laryngeal carcinoma treatment at three centres (2007-2016) were retrospectively analysed using descriptive statistics and survival curves. RESULTS: Of 179 T3 laryngeal carcinomas, 68 were treated with laryngectomies, 57 with chemoradiotherapy and 32 with radiotherapy. There was no significant five-year survival difference between treatment with laryngectomy (34.1 per cent) and chemoradiotherapy (48.6 per cent) (p = 0.184). The five-year overall survival rate for radiotherapy (12.5 per cent) was significantly inferior compared to laryngectomy and chemoradiotherapy (p = 0.003 and p < 0.001, respectively). The recurrence rates were 22.1 per cent for laryngectomy, 17.5 per cent for chemoradiotherapy and 50 per cent for radiotherapy. There were significant differences in recurrence rates when laryngectomy (p = 0.005) and chemoradiotherapy (p = 0.001) were compared to radiotherapy. CONCLUSION: Laryngectomy and chemoradiotherapy had significantly higher five-year overall survival and lower recurrence rates compared with radiotherapy alone. Laryngectomy should be considered in patients unsuitable for chemotherapy, as it may convey a significant survival advantage over radiotherapy alone.


Assuntos
Carcinoma/terapia , Quimiorradioterapia/métodos , Neoplasias Laríngeas/patologia , Laringectomia/métodos , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Quimiorradioterapia/estatística & dados numéricos , Inglaterra/epidemiologia , Feminino , Humanos , Neoplasias Laríngeas/mortalidade , Laringectomia/estatística & dados numéricos , Masculino , Pessoa de Meia-Idade , Invasividade Neoplásica/patologia , Recidiva Local de Neoplasia/epidemiologia , Radioterapia/métodos , Radioterapia/estatística & dados numéricos , Análise de Sobrevida , Taxa de Sobrevida , Resultado do Tratamento , Adulto Jovem
2.
Eur Arch Otorhinolaryngol ; 273(4): 827-35, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-25567344

RESUMO

The treatment of post-surgical hypoparathyroidism (following thyroid or parathyroid surgery) is challenging. Presently, this condition is treated with calcium and vitamin D supplements rather than replacing the missing parathyroid hormone. Not only is it challenging to maintain normocalcaemia, but concerns of hypercalciuria and ectopic calcification have also been raised using these supplements. There is an ongoing debate whether recombinant parathyroid hormone (rPTH), which as yet is unlicensed for treating hypoPTH, may offer a more physiological solution. The objective of the study was to assess the effectiveness and safety of rPTH in maintaining normocalcaemia and normocalcuria in hypoparathyroidism. This was a systematic review performed using independently developed search strategies including Medline, Embase, CINAHL, Cochrane, Zetoc, conference proceedings and a manual search until 15 July 2014. Data extraction was undertaken by one reviewer (YR). Studies were synthesised through narrative review with tabulation of results. Of 2,141 studies identified, only eleven studies fitted the inclusion criteria. These studies suggest that rPTH is useful in normalising serum calcium levels. Excretion of urinary calcium levels is reduced with PTH 1-34 but remained unchanged in a number of studies using PTH 1-84. Recombinant PTH is well tolerated. The majority of studies included post-surgical hypoparathyroidism with marked heterogeneity. Further prospective, larger, long-term trials are necessary to evaluate the long-term efficacy and adverse profile of rPTH, including head to head comparisons between PTH 1-34 and PTH 1-84.


Assuntos
Hipoparatireoidismo/tratamento farmacológico , Hormônio Paratireóideo/administração & dosagem , Gerenciamento Clínico , Humanos , Proteínas Recombinantes/administração & dosagem
3.
J Laryngol Otol ; 127(11): 1103-5, 2013 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-24169266

RESUMO

OBJECTIVE: To investigate whether multiple-use Co-phenylcaine Forte® spray was more cost-effective than single-use vials. METHODS: A literature review was conducted to determine the risk of cross-contamination associated with multiple-use topical nasal anaesthetic spray. The costs of multiple-use Co-phenylcaine Forte and single-use co-phenylcaine were compared, and potential savings were calculated. The cost of procuring these drugs from other sources was also examined. RESULTS: Switching to multiple-use Co-phenylcaine Forte spray would lead to at least 40 per cent savings if bought from our local retailer. Potential savings of more than 70 per cent could be made if the drugs were procured from sources other than our local distributor. CONCLUSION: Multiple-use Co-phenylcaine Forte spray is safe to use and more cost-effective than single-use vials. This paper illustrates how money can be saved within the National Health Service through changes in drug procurement. Similar cost savings to those calculated for our department could be made in other ENT departments nationally, depending on their annual consumption of co-phenylcaine.


Assuntos
Lidocaína/economia , Descongestionantes Nasais/economia , Fenilefrina/economia , Análise Custo-Benefício , Combinação de Medicamentos , Contaminação de Medicamentos/economia , Contaminação de Medicamentos/prevenção & controle , Substituição de Medicamentos/economia , Humanos , Lidocaína/administração & dosagem , Descongestionantes Nasais/administração & dosagem , Sprays Nasais , Fenilefrina/administração & dosagem
4.
J Laryngol Otol ; 127(8): 760-7, 2013 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23822869

RESUMO

AIM: To conduct a questionnaire survey of speech and language therapists providing and managing surgical voice restoration in England. METHOD: National Health Service Trusts registering more than 10 new laryngeal cancer patients during any one year, from November 2009 to October 2010, were identified, and a list of speech and language therapists compiled. A questionnaire was developed, peer reviewed and revised. The final questionnaire was e-mailed with a covering letter to 82 units. RESULTS: Eighty-two questionnaires were distributed and 72 were returned and analysed, giving a response rate of 87.8 per cent. Forty-four per cent (38/59) of the units performed more than 10 laryngectomies per year. An in-hours surgical voice restoration service was provided by speech and language therapists in 45.8 per cent (33/72) and assisted by nurses in 34.7 per cent (25/72). An out of hours service was provided directly by ENT staff in 35.5 per cent (21/59). Eighty-eight per cent (63/72) of units reported less than 10 (emergency) out of hours calls per month. CONCLUSION: Surgical voice restoration service provision varies within and between cancer networks. There is a need for a national management and care protocol, an educational programme for out of hours service providers, and a review of current speech and language therapist staffing levels in England.


Assuntos
Atitude do Pessoal de Saúde , Neoplasias de Cabeça e Pescoço/reabilitação , Laringectomia/reabilitação , Fonoterapia/organização & administração , Plantão Médico , Inglaterra , Pesquisas sobre Atenção à Saúde , Necessidades e Demandas de Serviços de Saúde , Humanos , Neoplasias Laríngeas/complicações , Otolaringologia , Procedimentos Cirúrgicos Otorrinolaringológicos , Inquéritos e Questionários , Distúrbios da Voz/terapia , Carga de Trabalho
5.
J Laryngol Otol ; 124(8): 934-5, 2010 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-20067649

RESUMO

OBJECTIVE: We report a rare case of a 51-year-old woman with ocular and nasal infestation by Oestrus ovis. METHOD: Clinical case report and review of current literature regarding nasal and ophthalmomyiasis. RESULTS: Myiasis is infestation of the tissues and organs of vertebrates by certain dipteran fly larvae. Oestrus ovis myiasis is endemic in the region from North Africa to South Asia, but few cases are reported within the UK. A 51-year-old patient presented and was treated successfully in Sunderland Royal Hospital for combined ocular and nasal infestation with Oestrus ovis. CONCLUSIONS: Oestrus ovis has a largely subtropical distribution; however, it is important to remember the diversity of disease which can present within the UK from an external source. This point is illustrated by this rare case, which highlights the fact that prompt treatment can avoid poor outcomes for our patients.


Assuntos
Infecções Oculares Parasitárias/parasitologia , Miíase/parasitologia , Doenças Nasais/parasitologia , Animais , Dípteros/crescimento & desenvolvimento , Infecções Oculares Parasitárias/terapia , Feminino , Humanos , Larva , Pessoa de Meia-Idade , Mucosa Nasal/parasitologia , Mucosa Nasal/patologia , Doenças Nasais/terapia , Viagem , Reino Unido
6.
Int J Pediatr Otorhinolaryngol ; 71(5): 757-62, 2007 May.
Artigo em Inglês | MEDLINE | ID: mdl-17321605

RESUMO

INTRODUCTION: Otolaryngology is the surgical speciality with the highest paediatric workload, accounting for 29% of the total. Children are not miniature adults and require specially trained staff, equipment, facilities and an environment appropriate to their needs. Documents from the Department of Health and the Royal Colleges of Surgeons and Anaesthetists have been published outlining national standards and recommendations for paediatric surgical service provision. We undertook an audit to assess the current state of paediatric services in ENT in England and Wales and how they conform to these guidelines. METHOD: A database of ENT departments in England and Wales was constructed and a postal questionnaire sent to a named consultant in each unit. The questionnaire encompassed the areas of recommendation outlined in the aforementioned reports. Respondents were also asked to state the kind of hospital in which they worked so a further breakdown of the results could be made. RESULTS: One hundred and eighty-nine units were included in the audit with a response rate of 56%. Structurally the documents recommend that each unit has a dedicated named paediatric ENT consultant and a designated clinical lead for children's surgery. This is being met in 54.7% and 56.6%, respectively. Omitting the specialist stand alone group the paediatric facilities in theatre were of a lower standard and overall only 30% met the requirements set by the reports. This theme continues when analysing the data of the provision of anaesthetic services with only 50% of the small district general hospitals having the appropriate level of supervision and expertise. One of the worst met targets is that of acute pain service being provided in only 26% of the hospitals that responded. Overall there is a common theme with the specialist stand alone units scoring the highest and the small district general hospitals scoring the lowest. CONCLUSION: This audit reveals that we are not meeting the guidelines in nearly 50% of the targeted areas. Paediatric care should be "child centred" and if we are not able to provide this specialised care then paediatric surgical services could be forced into centralisation.


Assuntos
Serviços de Saúde da Criança/provisão & distribuição , Serviços de Saúde da Criança/estatística & dados numéricos , Auditoria Médica/estatística & dados numéricos , Otolaringologia/estatística & dados numéricos , Procedimentos Cirúrgicos Otorrinolaringológicos/estatística & dados numéricos , Criança , Pré-Escolar , Inglaterra/epidemiologia , Feminino , Hospitais Gerais/estatística & dados numéricos , Hospitais Especializados/estatística & dados numéricos , Humanos , Masculino , Dor Pós-Operatória/tratamento farmacológico , Dor Pós-Operatória/etiologia , Índice de Gravidade de Doença , País de Gales/epidemiologia
8.
Clin Otolaryngol Allied Sci ; 27(5): 304-9, 2002 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-12383285

RESUMO

Thyroid surgery has been traditionally a general surgical practice, but recently more otolaryngologists have been offering a thyroid service. We have quantified thyroid surgery performed by the different specialties, and looked more closely at the practice of otolaryngologists. Data was obtained from the Department of Health for UK thyroid surgery in all specialties for the year 1998-99 and validated against a survey of members of the British Association of Otolaryngologists-Head & Neck Surgeons (BAO-HNS). The use of investigations of a simple clinical case (solitary thyroid nodule) was compared with best practice. General surgeons still perform the majority of thyroid surgery (83%) but ENT surgeons now perform significant numbers (15.4% of all cases), which translates to 1499 cases per annum. A total of 102 BAO-HNS members were performing thyroid surgery with an average case-load of 19.1 per year. In total, 35% of ENT surgeons see thyroid patients in multidisciplinary clinics. The choice of investigation is consistent with European guidelines. ENT surgeons are doing significant amounts of thyroid surgery and the numbers appear to be increasing. The formation of multidisciplinary teams including general surgeons and otolaryngologists who are committed to subspecialization can only improve both training and treatment outcomes.


Assuntos
Otolaringologia/estatística & dados numéricos , Tireoidectomia/estatística & dados numéricos , Cirurgia Geral/estatística & dados numéricos , Humanos , Doenças da Glândula Tireoide/cirurgia , Reino Unido
9.
J Laryngol Otol ; 115(10): 819-20, 2001 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11667996

RESUMO

The incidence of acute epiglottitis in children has declined with the introduction of the Haemophilus influenzae b vaccine in 1992. We report a case of acute epiglottitis in a child secondary to an immunocompromised state. We suggest that when acute epiglottitis is diagnosed in a child we should ensure there is no underlying predisposing condition.


Assuntos
Epiglotite/etiologia , Histiocitose de Células não Langerhans/complicações , Infecções Estreptocócicas/complicações , Doença Aguda , Pré-Escolar , Epiglotite/microbiologia , Epiglotite/virologia , Infecções por Vírus Epstein-Barr/complicações , Histiocitose de Células não Langerhans/microbiologia , Histiocitose de Células não Langerhans/virologia , Humanos , Masculino , Infecções por Vírus Respiratório Sincicial/complicações
10.
J Clin Endocrinol Metab ; 86(6): 2709-16, 2001 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-11397875

RESUMO

Angiogenesis is coordinated with follicular cell growth in goitrogenesis. The angiopoietins, Ang-1 and Ang-2, are angiogenic growth factors acting through Tie-2, a tyrosine kinase receptor. We have examined the expression and regulation of the angiopoietins and Tie-2 in human and rat thyroids. In human goiters there was increased Tie-2 immunostaining, compared with that in normal thyroids, on both follicular and endothelial cells. In an induced goiter in rats, in situ hybridization showed increased expression of messenger ribonucleic acids (mRNAs) for Tie-2 and Ang-1 in follicular cells. As Tie-2 has previously been believed to be restricted to cells of endothelial lineage in adults, we examined its expression further in isolated follicular cells. Tie-2 and Ang-1 mRNA expression in human thyrocytes was confirmed by ribonuclease protection assay. Ang-2 mRNA was not detected in human cultures or rat thyroids. In both human follicular cell cultures and FRTL-5 cells, immunoblotting showed that Tie-2 expression was increased by TSH and agents that increased intracellular cAMP. In conclusion, we have demonstrated the expression of Tie-2 and Ang-1 in thyroid epithelial and endothelial cells, and have shown the regulation of Tie-2 by TSH and cAMP in follicular cells. Tie-2 expression is increased in goiter in both humans and rats, consistent with a role in goitrogenesis.


Assuntos
AMP Cíclico/fisiologia , Bócio/metabolismo , Receptores Proteína Tirosina Quinases/metabolismo , Glândula Tireoide/metabolismo , Hormônio Liberador de Tireotropina/fisiologia , Angiopoietina-1 , Células Cultivadas , Humanos , Glicoproteínas de Membrana/genética , RNA Mensageiro/metabolismo , Receptores Proteína Tirosina Quinases/genética , Receptor TIE-2 , Valores de Referência , Glândula Tireoide/citologia , Glândula Tireoide/patologia
11.
J Laryngol Otol ; 113(7): 680-2, 1999 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-10605572

RESUMO

Free jejunum has been commonly tubed to provide a reconstructive pharyngeal conduit following pharyngolaryngectomy. It is also common practice to repair small oral and oro-pharyngeal defects with skin-lined flaps i.e. radial free forearm or pectoralis major myocutaneous flap. Free jejunal patch flaps can provide cover for large defects, secrete mucus, tolerate radiotherapy well and do not contract. The operation is associated with a low morbidity and early return of swallowing is feasible. Here we describe the functional results of free jejunal patch flap reconstruction of extensive oral and oro-pharyngeal defects.


Assuntos
Jejuno , Boca/cirurgia , Orofaringe/cirurgia , Cirurgia Plástica/métodos , Retalhos Cirúrgicos , Adulto , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Neoplasias Bucais/cirurgia , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...